$CCXI News Article - HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm, Application Deadline Approaching in Securities Fraud Action
https://marketwirenews.com/news-releases/hage...65383.html